FY2026 EPS Estimates for McKesson Boosted by Leerink Partnrs

McKesson Co. (NYSE:MCK) – Equities research analysts at Leerink Partnrs raised their FY2026 EPS estimates for shares of McKesson in a note issued to investors on Thursday, November 7th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings of $37.21 per share for the year, up from their previous estimate of $35.93. The consensus estimate for McKesson’s current full-year earnings is $32.81 per share. Leerink Partnrs also issued estimates for McKesson’s FY2027 earnings at $41.97 EPS.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 EPS for the quarter, beating analysts’ consensus estimates of $6.88 by $0.19. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. The company had revenue of $93.65 billion for the quarter, compared to analyst estimates of $89.33 billion. During the same period in the prior year, the firm posted $6.23 EPS. The company’s quarterly revenue was up 21.3% on a year-over-year basis.

Several other research analysts also recently weighed in on the stock. Citigroup lowered their price objective on shares of McKesson from $670.00 to $630.00 and set a “buy” rating on the stock in a report on Tuesday, September 10th. Leerink Partners lowered their price objective on shares of McKesson from $665.00 to $630.00 and set an “outperform” rating on the stock in a report on Monday, October 7th. Robert W. Baird upgraded shares of McKesson from a “neutral” rating to an “outperform” rating and upped their price objective for the stock from $531.00 to $688.00 in a report on Thursday, November 7th. StockNews.com upgraded shares of McKesson from a “hold” rating to a “buy” rating in a report on Wednesday, November 6th. Finally, Mizuho increased their target price on shares of McKesson from $540.00 to $570.00 and gave the company a “neutral” rating in a report on Thursday, August 8th. Two equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $625.64.

McKesson Stock Up 0.3 %

McKesson stock opened at $617.68 on Monday. McKesson has a 12-month low of $431.35 and a 12-month high of $637.51. The firm’s fifty day moving average is $514.12 and its 200 day moving average is $552.38. The company has a market capitalization of $80.10 billion, a PE ratio of 31.99, a PEG ratio of 1.39 and a beta of 0.44.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Monday, December 2nd will be issued a $0.71 dividend. This represents a $2.84 annualized dividend and a yield of 0.46%. The ex-dividend date is Monday, December 2nd. McKesson’s dividend payout ratio is 14.71%.

Insider Buying and Selling

In related news, CEO Brian S. Tyler sold 3,753 shares of the stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $561.10, for a total value of $2,105,808.30. Following the completion of the sale, the chief executive officer now directly owns 78,586 shares of the company’s stock, valued at approximately $44,094,604.60. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.11% of the stock is currently owned by insiders.

Institutional Investors Weigh In On McKesson

Institutional investors have recently added to or reduced their stakes in the stock. Fisher Asset Management LLC grew its holdings in shares of McKesson by 50.0% in the third quarter. Fisher Asset Management LLC now owns 1,242 shares of the company’s stock valued at $614,000 after purchasing an additional 414 shares in the last quarter. Summit Trail Advisors LLC grew its holdings in shares of McKesson by 11.9% in the third quarter. Summit Trail Advisors LLC now owns 1,401 shares of the company’s stock valued at $693,000 after purchasing an additional 149 shares in the last quarter. Centaurus Financial Inc. grew its holdings in shares of McKesson by 518.4% in the third quarter. Centaurus Financial Inc. now owns 2,152 shares of the company’s stock valued at $1,064,000 after purchasing an additional 1,804 shares in the last quarter. Larson Financial Group LLC grew its holdings in shares of McKesson by 4.3% in the third quarter. Larson Financial Group LLC now owns 1,141 shares of the company’s stock valued at $564,000 after purchasing an additional 47 shares in the last quarter. Finally, MGB Wealth Management LLC grew its holdings in shares of McKesson by 6.2% in the third quarter. MGB Wealth Management LLC now owns 3,356 shares of the company’s stock valued at $1,655,000 after purchasing an additional 197 shares in the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.